Search Results - "Bulgheroni, Elisabetta"
-
1
Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors
Published in The Journal of pharmacology and experimental therapeutics (01-08-2013)“…The neuropeptides oxytocin (OT) and vasopressin (AVP) have been shown to play a central role in social behaviors; as a consequence, they have been recognized…”
Get more information
Journal Article -
2
Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism
Published in Biological psychiatry (1969) (01-05-2011)“…Background Oxytocin (OT) has been suggested as a treatment to improve social behavior in autistic patients. Accordingly, the OT ( Oxt −/− ) and the OT receptor…”
Get full text
Journal Article -
3
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells
Published in Chest (01-08-2016)“…A young woman received a diagnosis of abdominal, sporadic lymphangioleiomyomatosis (LAM) and multiple abdominal lymphangioleiomyomas and was referred for…”
Get full text
Journal Article -
4
Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation
Published in PloS one (26-09-2013)“…Activated lymphocytes release nano-sized vesicles (exosomes) containing microRNAs that can be monitored in the bloodstream. We asked whether elicitation of…”
Get full text
Journal Article -
5
Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor
Published in Journal of neurochemistry (01-09-2010)“…J. Neurochem. (2010) 114, 1424-1435. Oxytocin receptor is a seven transmembrane receptor widely expressed in the CNS that triggers Gi or Gq protein-mediated…”
Get full text
Journal Article -
6
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses
Published in Molecules (Basel, Switzerland) (22-05-2009)“…Considering as a lead molecule the chemokine CXCR4 receptor antagonist AMD-3100, which shows significant anti-HIV activity in vitro and in vivo, we…”
Get full text
Journal Article -
7
Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
Published in American journal of respiratory cell and molecular biology (01-02-2024)Get more information
Journal Article -
8
Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene
Published in Chest (01-08-2022)“…Lymphangioleiomyomatosis (LAM) and pulmonary Langerhans cell histiocytosis (PLCH) are cystic lung diseases in which a neoplastic cell is thought to be…”
Get full text
Journal Article -
9
Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity
Published in The Journal of biological chemistry (17-02-2017)“…Upon T cell receptor stimulation, CD4+ T helper (Th) lymphocytes release extracellular vesicles (EVs) containing microRNAs. However, no data are available on…”
Get full text
Journal Article -
10
Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections
Published in Journal of Virology (01-10-2000)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation: e75348
Published in PloS one (01-09-2013)“…Activated lymphocytes release nano-sized vesicles (exosomes) containing microRNAs that can be monitored in the bloodstream. We asked whether elicitation of…”
Get full text
Journal Article -
12
Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
Published in Journal of antimicrobial chemotherapy (01-03-2004)“…Background: Despite the increasing number of antiretroviral compounds, the number of useful drug regimens is limited owing to the high frequency of…”
Get full text
Journal Article -
13
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol
Published in AIDS research and human retroviruses (01-09-2005)“…Tucaresol, a Schiff base-forming compound that is shown to enhance cytotoxic T cell responses and the production of type 1 cytokines, represents a potentially…”
Get more information
Journal Article -
14
Absence of New Thymidine-Associated Mutations and Evidence of an Immune Virologic Response Over a 12-Month Period in a Cohort of Antiretroviral-Experienced HIV-1-Infected Subjects Treated With Tenofovir Combination Therapy
Published in Journal of acquired immune deficiency syndromes (1999) (01-10-2005)Get full text
Journal Article -
15
Efficacy and tolerability of multiple drug therapy in HIV-infected children
Published in The Journal of infection (01-06-2005)“…To characterize the efficacy and tolerability of multiple drug therapy (MDT) among heavily pre-treated HIV-infected children. An observational study of seven…”
Get full text
Journal Article -
16
Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility
Published in Journal of clinical virology (2004)“…Introduction: Multiple amino acid changes in the reverse transcriptase (RT) enzyme of the human immunodeficiency virus 1 (HIV-1) confer simultaneous resistance…”
Get full text
Journal Article -
17
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects
Published in Journal of antimicrobial chemotherapy (01-02-2002)Get full text
Journal Article -
18
Virological response in multidrug-experienced hiv-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
Published in Antiviral therapy (01-03-2001)“…The aim of this study (the RESCUE trial) was to verify the effect of a shift from a lamivudine-containing to a didanosine-containing regimen on viral…”
Get full text
Conference Proceeding Journal Article -
19
In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs
Published in Antiviral therapy (01-09-2000)“…Compounds that can block the CXCR4 chemokine receptor are a promising new class of antiretroviral agents. In these experiments we studied the effect of a…”
Get full text
Journal Article -
20
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
Published in Antiviral therapy (01-01-1998)“…We examined the in vitro phenotypic and genotypic profiles of an extensively passaged human immunodeficiency virus type 1 clinical isolate which has been…”
Get more information
Journal Article